Valeant Canada Selects IMS Health’s Fully Integrated Customer Engagement Solution For Commercial Effectiveness
03 February 2016 - 1:15AM
Business Wire
Seamlessly Combines Nexxus Mobile
Intelligence CRM, Multi-Channel Marketing, Data Warehousing and BI
Analytics for Enriched Customer Interactions
IMS Health (NYSE:IMS) today announced a multi-year agreement
with Valeant Canada, a business unit of Valeant Pharmaceuticals, to
deploy IMS Health’s next-generation Orchestrated Customer
Engagement (OCE) solution for advancing commercial effectiveness.
The OCE solution for Valeant Canada integrates Nexxus™ Mobile
Intelligence CRM, Nexxus Marketing, cloud-based data warehousing
and business intelligence analytics—leveraging IMS Heath’s
industry-leading information and technology services to deliver
intelligence and enhanced sales and marketing performance for
improved customer interactions.
IMS Health’s solution uniquely aligns mission-critical
healthcare information and innovative SaaS applications for sales,
marketing and market access—empowering life sciences organizations
to better coordinate customer engagement and achieve their
commercial goals.
Tightly synchronized with the IMS One™ cloud platform, OCE
connects and streamlines complex processes in commercial
management, from multi-channel marketing and social media
monitoring to analytics for performance management. This end-to-end
approach addresses the challenge of strengthening the relationship
between life sciences companies and their customers, while
increasing efficiency across all communication channels and
boosting marketing ROI.
“We selected IMS Health’s integrated CRM, multi-channel
marketing and data solutions to leverage our sales team’s
strengths, while increasing our investment in tools that coordinate
all channels of communication,” said Jacques Dessureault, president
and general manager of Valeant Canada. “Valeant Canada is built on
a history of continuous innovation, and the speed and flexibility
of IMS Health’s capabilities will make our interactions with
customers even more efficient and productive.”
Valeant Canada is focused on empowering its commercial teams
with relevant insights and a 360-degree view of their customers for
excellence in sales execution. The company wanted to quickly
implement a scalable solution that makes information and analytics
easily accessible to its sales, marketing and technology teams,
whenever and wherever they choose. With OCE, Valeant Canada can
link more extensive and granular data with agile cloud-based
applications, enabling a fully coordinated approach to the
increasingly complex multi-channel and multi-stakeholder market
environment.
“We’re excited to collaborate with Valeant Canada to help them
uncover valuable insights and drive faster, more effective
decisions,” said Michael Brogan, president of IMS Health Canada.
“With our orchestrated customer engagement solution, Valeant can
now optimize workflows across commercial functions and more closely
align market engagement with its brand strategy.”
For more information about IMS Health solutions, visit
www.imshealth.com.
About Valeant Pharmaceuticals
Valeant Pharmaceuticals is a multinational specialty
pharmaceutical company that develops, manufactures and markets a
broad range of pharmaceutical products primarily in the areas of
dermatology, gastrointestinal disorder, eye health, neurology and
branded generics.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
end-to-end solutions to measure and improve their performance. Our
7,500 services experts connect configurable SaaS applications to
10+ petabytes of complex healthcare data in the IMS One™ cloud
platform, delivering unique insights into diseases, treatments,
costs and outcomes. The company’s 15,000 employees blend global
consistency and local market knowledge across 100 countries to help
clients run their operations more efficiently. Customers include
pharmaceutical, consumer health and medical device manufacturers
and distributors, providers, payers, government agencies,
policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160202005973/en/
IMS HealthTor Constantino,
+1-484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024